Oral Wegovy Clinical Trial Results: OASIS 4 The FDA approval was based on the OASIS 4 clinical triala 64-week study examining oral semaglutide 25mg in 307 adults with obesity
During IV: What to expect at the clinic, from arrival to the drip itself
This FDA-approved treatment aids in reducing appetite and promoting fat loss, supporting your journey toward a healthier lifestyle
Tirzepatide is a dual GIP/GLP-1 agonist with ~5-day half-life vs semaglutide's ~7-day half-life
Smooths wrinkles and fine lines, improves skin firmness, boosts collagen production GHK-Cu A naturally occurring copper peptide referenced for regenerative effects on skin, hair, and tissue
Our Vitamin B12 shot delivers a potent dose of this essential nutrient directly into your bloodstream, bypassing the digestive system and ensuring maximum absorption